A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-04-22) →
What happened
Dongsung Pharmaceutical updated the terms of convertible bonds to raise US$47.5M, about 56.4% of its market value.
For context, this raise equals about 56.4% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$47.5M |
| vs. market value | 56.4% |
| Filed | 2026-04-09, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260409001294 → open original filing |
Versions of this filing
- 2026-03-27Original
- 2026-04-09Amendment 1 (this page)
- 2026-04-22Amendment 2
Source: DART. Information only, not investment advice.